Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
  1. 4 Grant or award Secretary & VP Finance & Admin acquired 68,000 shares (grant or award)
  2. 4 Grant or award Director acquired 10,000 shares (grant or award)
  3. 4 Grant or award Director acquired 10,000 shares (grant or award)
  4. 4 Grant or award Director acquired 10,000 shares (grant or award)
  5. 4 Grant or award President & CEO acquired 126,000 shares (grant or award)
  6. 4 Grant or award Director acquired 10,000 shares (grant or award)
  7. 4 Grant or award Director acquired 10,000 shares (grant or award)
  8. 4 Open-market buy President & CEO bought 6,000 shares at $1.63 ($9,780)
  9. 4 Open-market buy President & CEO bought 1,953 shares at $2.56 ($5,000)
  10. 4 Grant or award Director acquired 10,000 shares (grant or award)
  11. 4 Grant or award Director acquired 10,000 shares (grant or award)
  12. 4 Grant or award Director acquired 10,000 shares (grant or award)
  13. 4 Grant or award Director acquired 10,000 shares (grant or award)
  14. 4 Grant or award Director acquired 10,000 shares (grant or award)
  15. 4 Open-market buy Director bought 682 shares at $3.15 ($2,148)
  16. 4 Open-market buy President & CEO bought 2,500 shares at $3.03 ($7,575)
  17. 4 Grant or award Secretary & VP Finance & Admin acquired 34,600 shares (grant or award)
  18. 4 Open-market buy President & CEO bought 2,000 shares at $2.50 ($5,000)
  19. 4 Shares withheld for taxes President & CEO gave up 673 shares (to pay taxes)
  20. 4 Grant or award Director acquired 300,000 shares (grant or award)

Page 5 of 15 · 281 filings